Keyphrases
Tumor
100%
Radiosensitization
100%
Zinc Finger E-box Binding Homeobox 1 (ZEB1)
100%
Ubc13
100%
MiR-205
100%
MicroRNA
42%
Local Recurrence
14%
Cell-Associated
14%
Metastasis
14%
Tumor Cells
14%
Radioresistant
14%
Radiosensitivity
14%
Distant Metastasis
14%
Ataxia Telangiectasia mutated
14%
Breast Cancer Cells
14%
Radioresistance
14%
Relapse-free Survival
14%
New Therapeutic Strategies
14%
Therapeutic Delivery
14%
Breast Cancer Patients
14%
Epithelial-mesenchymal Transition
14%
Drug Resistance
14%
DNA Damage Repair
14%
Distant Relapse
14%
Xenograft Model
14%
Radioresistant Tumors
14%
Therapy Resistance
14%
Deubiquitinating Enzyme
14%
Metastatic Relapse
14%
Nanoliposomes
14%
Tumor Radioresistance
14%
Radiation-protective Agents
14%
Medicine and Dentistry
Radiosensitizer
100%
Tumor
100%
Transcription Factor ZEB1
100%
microRNA 205
100%
Radiosensitivity
50%
microRNA
50%
Breast Cancer
33%
Metastatic Carcinoma
16%
Tumor Cell
16%
Cancer Cell
16%
Recurrent Disease
16%
Xenograft
16%
Mesenchymal-Epithelial Transition
16%
Drug Resistance
16%
Recurrence Free Survival
16%
Ataxia Telangiectasia
16%
DNA Repair
16%
Ubiquitin Conjugating Enzyme 13
16%
Therapy Resistance
16%
Biochemistry, Genetics and Molecular Biology
Radiosensitivity
100%
Radiosensitizer
100%
Transcription Factor ZEB1
100%
MicroRNA
66%
Cancer Cell
33%
Ataxia Telangiectasia Mutated
33%
Ubiquitin-Conjugating Enzyme
33%
DNA Repair
33%
Recurrence Free Survival
33%
Mesenchymal-Epithelial Transition
33%
Drug Resistance
33%
Nanoliposome
33%
Immunology and Microbiology
Radioresistance
100%
Transcription Factor ZEB1
100%
Cancer Cell
33%
DNA Repair
33%
Tumor Cell
33%
Xenograft
33%
Epithelial Mesenchymal Transition
33%
Ataxia Telangiectasia
33%
Drug Resistance
33%
Ubiquitins
33%
Recurrence Free Survival
33%
Pharmacology, Toxicology and Pharmaceutical Science
Radiosensitizing Agent
100%
microRNA 205
100%
Transcription Factor ZEB1
100%
microRNA
50%
Breast Cancer
33%
Recurrent Disease
16%
Ataxia Telangiectasia
16%
Recurrence Free Survival
16%
Drug Resistance
16%
Therapy Resistance
16%
Ubiquitin Conjugating Enzyme 13
16%